Idexx Laboratories | IDXX - Cash And Equivalent


Idexx Laboratories reported $200.53M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Accuray USD 41.29M 22.05M Dec/2025
Align Technology USD 1.06B 35.07M Mar/2026
AngioDynamics USD 41.64M 14.26M Sep/2025
Dentsply International USD 190M 136M Mar/2026
Dexcom USD 1.12B 200.5M Mar/2026
Edwards Lifesciences USD 2.4B 538M Mar/2026
Fujifilm JPY 160.88B 906M Sep/2025
Globus Medical USD 560.95M 34.79M Mar/2026
Henry Schein USD 138M 18M Mar/2026
Idexx Laboratories USD 200.53M 20.46M Mar/2026
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
Intuitive Surgical USD 7.98B 1.05B Mar/2026
Masimo USD 124.6M 187.7M Mar/2026
Neogen USD 159.9M 14.56M Dec/2025
Orthofix International USD 120.28M 38.25M Mar/2026
Phibro Animal Health USD 54.93M 557K Mar/2026
ResMed USD 1.66B 243.44M Mar/2026
Roche Holding CHF 7.55B 579M Jun/2025
Steris USD 423.7M 104.5M Dec/2025
Tandem Diabetes Care USD 179.32M 88.69M Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Zoetis USD 1.94B 369M Mar/2026